Up-regulation of DRAM2 promotes tolerance of bladder transitional cell carcinoma to gemcitabine

INTRODUCTION: Bladder transitional cell carcinoma (BTCC) is one of the most prevalent human malignant diseases. Gemcitabine is commonly applied in the treatment of BTCC while acquired gemcitabine resistance has caused a severe impediment to recovery. This study aimed to investigate the function of D...

Descripción completa

Detalles Bibliográficos
Autores principales: Azhati, Baihetiya, Maolakuerban, Naibijiang, Ma, Tao, Li, Xiaodong, Rexiati, Mulati
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2020
Materias:
Basic Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7444702/
https://www.ncbi.nlm.nih.gov/pubmed/32864010
http://dx.doi.org/10.5114/aoms.2020.93748

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7444702/
https://www.ncbi.nlm.nih.gov/pubmed/32864010
http://dx.doi.org/10.5114/aoms.2020.93748

Ejemplares similares